Awards of $10 Million in 2019 Granted to More Than 400 Organizations in 32 States
IRVINE, Calif., Dec. 19, 2019 /PRNewswire/ -- Allergan, Inc. (NYSE: AGN), a leading global pharmaceutical company, today announced that The Allergan Foundation has awarded a total of $10 million in charitable grants in 2019. The grants were donated to more than 400 organizations in 32 states as part of The Allergan Foundation’s commitment to providing a lasting and positive impact in the communities in which Allergan employees live and work. The 2019 grants bring The Allergan Foundation’s total donations in its 21-year history to approximately $95 million, including $45 million since 2015. “We at The Allergan Foundation are honored and proud to offer our support to the many organizations striving to make a difference in the health and wellbeing of our communities,” said Brent Saunders, Chairman of The Allergan Foundation and Chairman and CEO of Allergan. “We are privileged to work closely with many of these organizations whose missions are focused on Allergan’s key therapeutic areas including eye care, central nervous system, breast health and gastroenterology. We are delighted to contribute to their resources for improving patient treatment and care.” “Many of the groups supported by The Allergan Foundation are small, grassroots organizations with a focus on fulfilling a specific need in their community. Without their selfless effort and dedication, many of these needs would remain unfulfilled,” said Alex Kelly, President of The Allergan Foundation and Executive Vice President of Corporate Affairs at Allergan. The Allergan Foundation’s 2019 grants include support for the following:
The Allergan Foundation considers community grant applications on an annual basis from qualified U.S.-based tax-exempt public charities with innovative and leading programs and services, well-defined goals, a commitment to maximizing resources, and a reputation for meeting objectives and reporting measured results. About The Allergan Foundation The Allergan Foundation is a U.S.-based, private charitable foundation committed to providing a lasting and positive impact in the communities in which Allergan employees live and work. The Allergan Foundation focuses its support on charitable efforts dedicated to promoting access to quality healthcare and improving patient diagnosis, treatment, care and quality of life. Established in 1998, The Allergan Foundation has donated approximately $95 million to a wide variety of philanthropic pursuits globally. For more information, visit The Allergan Foundation website at www.AllerganFoundation.org. About Allergan plc Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a global pharmaceutical leader focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world. Allergan markets a portfolio of leading brands and best-in-class products primarily focused on four key therapeutic areas including medical aesthetics, eye care, central nervous system and gastroenterology. As part of its approach to delivering innovation for better patient care, Allergan has built one of the broadest pharmaceutical and device research and development pipelines in the industry. With colleagues and commercial operations located in approximately 100 countries, Allergan is committed to working with physicians, healthcare providers and patients to deliver innovative and meaningful treatments that help people around the world live longer, healthier lives every day. For more information, visit Allergan’s website at www.Allergan.com.
View original content to download multimedia:http://www.prnewswire.com/news-releases/allergan-foundation-giving-reaches-95-million-since-inception-300977621.html SOURCE Allergan plc | ||||||||||||||||||
Company Codes: NYSE:AGN |